Literature DB >> 1727886

Respiratory syncytial virus infections in pediatric liver transplant recipients.

C Pohl1, M Green, E R Wald, J Ledesma-Medina.   

Abstract

Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract infection in infants and young children. The charts of 17 children found to have RSV among 493 children who underwent liver transplantation between February 1985 and February 1991 were reviewed. The median age at diagnosis was 20 months. Median time of diagnosis was 24 days after transplantation. Thirteen patients developed nosocomial infections while convalescing from their transplant. Common symptoms included tachypnea, cough, fever, and congestion. Acute radiographic changes were seen in 12 patients. Two deaths were associated with progressive pulmonary disease and occurred in children with infection early in the postoperative period who were intubated before the onset of symptoms. RSV in children after liver transplantation has a clinical spectrum similar to that in normal children. Early onset of infection (less than 20 days) after transplantation and preexisting lung disease may predict more severe disease.

Entities:  

Mesh:

Year:  1992        PMID: 1727886     DOI: 10.1093/infdis/165.1.166

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Authors:  Karen A Robinson; Olaide A Odelola; Ian J Saldanha
Journal:  Cochrane Database Syst Rev       Date:  2016-07-20

Review 2.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

3.  Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?

Authors:  William A Prescott; David J Hutchinson
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

Review 4.  Targeting RSV with vaccines and small molecule drugs.

Authors:  Heather M Costello; William C Ray; Supranee Chaiwatpongsakorn; Mark E Peeples
Journal:  Infect Disord Drug Targets       Date:  2012-04

5.  Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.

Authors:  Kari Neemann; Alison Freifeld
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

6.  Respiratory syncytial virus infections in pediatric renal transplant recipients.

Authors:  R B Miller; B M Chavers
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 7.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Influenza-associated morbidity in children with cancer.

Authors:  Sarah K Tasian; Julie R Park; Emily T Martin; Janet A Englund
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

Review 9.  Community-acquired respiratory viruses.

Authors: 
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

10.  Lower respiratory tract viral infections in pediatric abdominal organ transplant recipients: a single hospital inpatient cohort study.

Authors:  Thy T Tran; Ivan A Gonzalez; Akin Tekin; Gwenn E McLaughlin
Journal:  Pediatr Transplant       Date:  2013-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.